| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 06/27/1995 | CA1336076C Metal radionuclide labeled proteins for diagnosis and therapy |
| 06/22/1995 | WO1995016996A1 Apparatus and method for the preparation of a radiopharmaceutical formulation |
| 06/22/1995 | WO1995016469A1 Multilayer lyophile for preparing radiopharmaceuticals |
| 06/22/1995 | WO1995016467A1 Gas mixtures useful as ultrasound contrast media |
| 06/22/1995 | WO1995016464A1 Controlled release of pharmaceutically active substances for immunotherapy |
| 06/22/1995 | WO1995016463A1 Radioactive compositions and their use for radiation ablation treatment |
| 06/22/1995 | WO1995014492A3 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
| 06/22/1995 | CA2178902A1 Controlled release of pharmaceutically active substances for immunotherapy |
| 06/22/1995 | CA2176562A1 Apparatus and method for the preparation of a radiopharmaceutical formulation |
| 06/20/1995 | US5426189 Dopamine receptor ligands and imaging agents |
| 06/20/1995 | US5425936 Useful for therapeutic, prophylactic and diagnostic purposes |
| 06/20/1995 | US5425935 Metallic radionuclide labelled 4-quinolone antibiotic for gamma ray scintigraphy diagnostic imaging |
| 06/15/1995 | WO1995016202A1 Labelling of nucleic acid analogue-peptide chimerae |
| 06/15/1995 | WO1995015979A1 Pretargeting methods and compounds |
| 06/15/1995 | WO1995015978A1 Pretargeting methods and compounds |
| 06/15/1995 | WO1995015770A1 Pretargeting methods and compounds |
| 06/15/1995 | WO1995015769A1 Preparation and use of immunoconjugates |
| 06/15/1995 | CA2178477A1 Pretargeting methods and compounds |
| 06/15/1995 | CA2178476A1 Pretargeting methods and compounds |
| 06/13/1995 | US5424402 Non-destructive method for radiolabelling biomolecules by halogenation |
| 06/13/1995 | US5424288 Prolonging time therapeutic agent remains in tumor |
| 06/13/1995 | US5424057 Medical diagnosis |
| 06/08/1995 | WO1995015341A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | WO1995015184A1 Substance for detecting amyloid deposition |
| 06/08/1995 | WO1995015171A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN |
| 06/08/1995 | CA2177991A1 A 46 kd human milk fat globule antigen |
| 06/08/1995 | CA2177584A1 Antibody against carcinoembryonic antigen (cea) |
| 06/08/1995 | CA2154869A1 Substance for detecting amyloid deposition |
| 06/07/1995 | EP0656115A1 Improved detection and therapy of lesions with biotin/avidin conjugates |
| 06/07/1995 | EP0656037A1 Metal-mediated cross-coupling with ring-metalated porphyrins |
| 06/07/1995 | EP0616532A4 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease. |
| 06/07/1995 | EP0454783B1 Site specific in-vivo activation of therapeutic drugs |
| 06/07/1995 | CN1103431A Determination of lymph nodes enriched in tumor reactive... |
| 06/06/1995 | US5422345 Useful in diagnosing or treating herpes viral infections |
| 06/06/1995 | US5422095 Low molecular weight polysaccharide complexes for radiation diagnosis |
| 06/01/1995 | WO1995014678A1 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production |
| 06/01/1995 | WO1995014493A1 Three-step pretargeting methods and compounds |
| 06/01/1995 | WO1995014492A2 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivity and kinetic-spatial profiles |
| 06/01/1995 | WO1995014491A2 Metal-ion chelates with acidic saccharides and glycosaminoglycans |
| 06/01/1995 | CA2177470A1 In vivo agents comprising radioactive metal-ion chelates with acidic saccharides and glycosaminoglycans, giving improved site-selective localization, uptake mechanism, sensitivityand kinetic-spatial profiles |
| 06/01/1995 | CA2177468A1 Metal-ion chelates with acidic saccharides and glycosaminoglycans |
| 06/01/1995 | CA2177271A1 1,4,7,10-tetraazacyclododecane derivatives, their use, pharmaceuticals containing them and process for their production |
| 06/01/1995 | CA2177037A1 Three-step pretargeting methods and compounds |
| 05/31/1995 | EP0654973A1 System of drug delivery to the lymphatic tissues |
| 05/30/1995 | US5420321 Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes |
| 05/30/1995 | US5419905 Kidneys |
| 05/30/1995 | US5419894 Complexing agents, complexes and complex salts |
| 05/30/1995 | US5419893 Aminopolycarboxylic acids and derivatives thereof for magnetic resonance imaging |
| 05/30/1995 | CA1335725C Method of diagnosing blood clots using fibrin-binding proteins |
| 05/30/1995 | CA1335720C Detection of necrotic malignant tissue and associated therapy |
| 05/26/1995 | WO1995014039A1 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (lbp) and methods of their use |
| 05/26/1995 | WO1995013832A1 Immobilized labelling method |
| 05/26/1995 | CA2175557A1 Immobilized labelling method |
| 05/24/1995 | EP0654043A1 Method for preparing a metal-radionuclide-labelled protein |
| 05/24/1995 | EP0438502B1 Technetium imaging agents |
| 05/23/1995 | US5417960 Gadolinium complexes, magnetic resonance imaging |
| 05/18/1995 | WO1995013374A2 Human and mouse very low density lipoprotein receptors and methods for use of such receptors |
| 05/18/1995 | WO1995013096A1 Labelled diagnostic compositions and methods of their use |
| 05/18/1995 | CA2176005A1 Labelled diagnostic compositions and methods of their use |
| 05/17/1995 | EP0652896A1 Peptide compounds |
| 05/17/1995 | EP0652885A1 Tetraazamacrocyclic metal complexes |
| 05/16/1995 | US5416016 Method for enhancing transmembrane transport of exogenous molecules |
| 05/16/1995 | US5415843 A lead chamber, multicompartment containers and loading device for radiotracers |
| 05/11/1995 | WO1995012613A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds |
| 05/11/1995 | WO1995012610A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 05/11/1995 | WO1995012417A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists |
| 05/11/1995 | CA2175795A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists |
| 05/11/1995 | CA2173845A1 Metal-bonding cystein-free peptides for diagnosis and therapy, process for producing them and pharmaceutical preparations containing these compounds |
| 05/11/1995 | CA2173844A1 N-alkyl peptide chelate formers, their metal complexes with radionuclides, processes for producing them and radio-pharmaceutical compositions containing these compounds |
| 05/10/1995 | EP0651799A1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 05/10/1995 | EP0651768A1 USE OF p97 AND IRON BINDING PROTEINS AS DIAGNOSTIC AND THERAPEUTIC AGENTS |
| 05/10/1995 | EP0651646A1 Therapeutic conjugates of toxins and drugs |
| 05/09/1995 | US5413779 Cocaine receptor binding ligands |
| 05/09/1995 | US5413778 Labelled monocyte chemoattractant protein material and medical uses thereof |
| 05/04/1995 | WO1995011901A1 Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging agents for neurodegenerative disorders |
| 05/04/1995 | WO1995011694A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same |
| 05/04/1995 | WO1995011672A1 Detection of h. pylori in the stomach |
| 05/04/1995 | CA2174933A1 Detection of h. pylori in the stomach |
| 05/03/1995 | EP0650735A2 Kit and method for pretargeting |
| 05/03/1995 | EP0650475A1 4-amino-n --(4-methyl-4-piperidinyl)-2-methoxybenzamides |
| 05/03/1995 | EP0650372A1 Compounds for cancer imaging and therapy |
| 05/02/1995 | US5411884 Monoclonal antibody L53 which recognizes a human tumor-associated antigen |
| 04/27/1995 | WO1995011234A1 Radiolabelled ligands for muscarinic receptors |
| 04/27/1995 | WO1995011045A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/27/1995 | CA2173972A1 Labeled chemotactic peptides to image focal sites of infection or inflammation |
| 04/26/1995 | EP0649857A1 Peptide having inflammation affinity and radioactive diagnostic containing the same |
| 04/26/1995 | EP0649532A1 Photoactivation of proteins for conjugation purposes |
| 04/26/1995 | EP0649434A1 Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses |
| 04/26/1995 | EP0649421A1 Hexadentate ligands useful in radiographic imaging agents |
| 04/26/1995 | EP0649302A1 Therapeutic and diagnostic use of modified polymeric microcapsules |
| 04/25/1995 | US5409911 Prostaglandin analog for treating osteoporosis |
| 04/25/1995 | US5409677 Contacting weak acid solution containing radionuclide with ligand which preferentially forms complex with radionuclide over precursor element, separating, releasing radionuclide |
| 04/23/1995 | CA2134051A1 Peptide having inflammation affinity and radioactive diagnostic containing the same |
| 04/20/1995 | WO1995010307A1 Radiation sensitization using texaphyrins |
| 04/20/1995 | WO1995010258A1 Inhibition of urinary calculi growth |
| 04/19/1995 | EP0648130A1 Radioiodinated benzovesamicol analogs for cholinergic nerve mapping |
| 04/19/1995 | EP0637251A4 Radiopharmaceuticals for imaging the heart. |
| 04/19/1995 | EP0624096A4 Taxol as a radiation sensitizer. |
| 04/19/1995 | EP0527755A4 Improved method for radiolabeling monovalent antibody fragments |
| 04/18/1995 | US5407962 Emulsions of highly fluorinated organic compounds for chemotherapy |